✦ LIBER ✦

Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer

✍ Scribed by Jeong, Hye Cheol; Lee, Sang Yeub; Lee, Sung Yong; Kim, Je Hyeong; Shin, Chol; Shim, Jae Jeong; In, Kwang Ho; Kang, Kyung Ho; Yoo, Se Hwa

Book ID: 119319437
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 155 KB
Volume: 53
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide plus cisplatin followed by con

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study

✍ Xenidis, N.; Kotsakis, A.; Kalykaki, A.; Christophyllakis, Ch.; Giassas, S.; Ken 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

✍ M Oka; M Fukuda; M Kuba; M Ichiki; T Rikimaru; H Soda; J Tsurutani; Y Nakamura; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Irinotecan plus cisplatin chemotherapy f

Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer

✍ Hanan A. Wahba; Amal A. Halim; Hend A. El-Hadaad 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 211 KB

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-stage small cell lung cancer (LS-SCLC)

✍ Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Takatani, H; Fukuda, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

P-62 Phase II trial of irinotecan plus c

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB